Catalysts / ETON
Upcoming FDA decisions and readouts we track for Eton Pharmaceuticals, each with the filing that announced it.
FreeBioList tracks 1 upcoming catalyst for Eton Pharmaceuticals (ETON, listed on Nasdaq). It concerns LIBERVANT (diazepam buccal film) (Seizure rescue treatment (label expansion to ages 6 and older)).
First on the list: the PDUFA date for LIBERVANT (diazepam buccal film) (Seizure rescue treatment (label expansion to ages 6 and older)), dated 29 Mar 2027.
The row links to an SEC filing (8-K or 6-K). It has been verified by a person reading the filing itself, most recently on 24 Oct 2026. The methodology page explains each status.
Background reading: What a PDUFA date is, and why the FDA doesn't publish them.
| Company ▾ | Drug ▾ | Effect / indication | Next catalyst ▾ | Phase / type ▾ | Status ▾ | Source | Options |
|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals ETON · Nasdaq | LIBERVANT (diazepam buccal film) | Seizure rescue treatment (label expansion to ages 6 and older) | 29 Mar 2027 in 154d |
PDUFA date | Verified | 8-K exhibit 99.1 ↗ | — |
FreeBioList